142 related articles for article (PubMed ID: 2451760)
21. Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies.
Ping LH; Lemon SM
J Virol; 1992 Apr; 66(4):2208-16. PubMed ID: 1312628
[TBL] [Abstract][Full Text] [Related]
22. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants.
Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P
J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244
[TBL] [Abstract][Full Text] [Related]
23. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
24. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
Thibodeau L; Lacroix M; Lecomte J; Fauvel M
Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
[TBL] [Abstract][Full Text] [Related]
25. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
[TBL] [Abstract][Full Text] [Related]
26. Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.
Reynolds C; Page G; Zhou H; Chow M
Virology; 1991 Sep; 184(1):391-6. PubMed ID: 1714663
[TBL] [Abstract][Full Text] [Related]
27. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
[TBL] [Abstract][Full Text] [Related]
28. Antigenic variation among 173 strains of type 3 poliovirus isolated in Finland during the 1984 to 1985 outbreak.
Huovilainen A; Kinnunen L; Ferguson M; Hovi T
J Gen Virol; 1988 Aug; 69 ( Pt 8)():1941-8. PubMed ID: 2841408
[TBL] [Abstract][Full Text] [Related]
29. Antigenic structure of chimeras of type 1 and type 3 poliovirus involving antigenic site 1.
Minor PD; Ferguson M; Katrak K; Wood D; John A; Howlett J; Dunn G; Burke K; Almond JW
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2543-51. PubMed ID: 1701474
[TBL] [Abstract][Full Text] [Related]
30. Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II.
Murdin AD; Wimmer E
J Virol; 1989 Dec; 63(12):5251-7. PubMed ID: 2479772
[TBL] [Abstract][Full Text] [Related]
31. Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1.
Leclerc C; Deriaud E; Mimic V; van der Werf S
J Virol; 1991 Feb; 65(2):711-8. PubMed ID: 1702841
[TBL] [Abstract][Full Text] [Related]
32. Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies.
Taniguchi K; Hoshino Y; Nishikawa K; Green KY; Maloy WL; Morita Y; Urasawa S; Kapikian AZ; Chanock RM; Gorziglia M
J Virol; 1988 Jun; 62(6):1870-4. PubMed ID: 2452893
[TBL] [Abstract][Full Text] [Related]
33. Mapping of antigenic domains in poliovirus VP1 involved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion.
Ketterlinus R; Wiegers K
Virology; 1994 Oct; 204(1):27-37. PubMed ID: 7522372
[TBL] [Abstract][Full Text] [Related]
34. Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.
Keil W; Wagner RR
Virology; 1989 Jun; 170(2):392-407. PubMed ID: 2471352
[TBL] [Abstract][Full Text] [Related]
35. Antigenic variation of poliovirus studied by means of monoclonal antibodies.
Crainic R; Blondel B; Horaud F
Rev Infect Dis; 1984; 6 Suppl 2():S535-9. PubMed ID: 6204369
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous mutations leading to antigenic variations in the glycoproteins of vesicular stomatitis virus field isolates.
Luo LZ; Li Y; Snyder RM; Wagner RR
Virology; 1990 Jan; 174(1):70-8. PubMed ID: 1688475
[TBL] [Abstract][Full Text] [Related]
37. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions.
Blondel B; Akacem O; Crainic R; Couillin P; Horodniceanu F
Virology; 1983 Apr; 126(2):707-10. PubMed ID: 6190311
[TBL] [Abstract][Full Text] [Related]
38. Construction and characterization of a poliovirus/rhinovirus antigenic hybrid.
Altmeyer R; Murdin AD; Harber JJ; Wimmer E
Virology; 1991 Oct; 184(2):636-44. PubMed ID: 1653493
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants.
Wu CT; Levine M; Homa F; Highlander SL; Glorioso JC
J Virol; 1990 Feb; 64(2):856-63. PubMed ID: 1688628
[TBL] [Abstract][Full Text] [Related]
40. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14.
Sherry B; Mosser AG; Colonno RJ; Rueckert RR
J Virol; 1986 Jan; 57(1):246-57. PubMed ID: 2416951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
